Starling Oncology, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $15.2M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.2M | 7.8% |
| Business Acquisitions | $150.0K | 1.0% |
| Other Investing | $7.5M | 49.3% |
| Working Capital | $2.8M | 18.5% |
| Net Cash Flow | $3.6M | 23.3% |